Targeted Molecular Imaging and Therapy Based on Nuclear and Optical Technologies

Area of Science:

• Medical Imaging
• Molecular Biology
• Biotechnology

Background:

• Nuclear imaging excels in quantitative analysis and deep tissue visualization, making it a clinical standard.
• Optical imaging, while limited in deep tissue penetration due to light scattering, offers non-ionizing properties and target-specific signal control.
• Both modalities are evolving for targeted applications, including nuclear therapy and phototherapy.

Purpose of the Study:

• To review target-specific imaging techniques.
• To discuss molecular targeted therapy approaches.
• To compare nuclear medicine and optical technologies in molecular imaging and therapy.

Main Methods:

• Comparative analysis of nuclear and optical imaging modalities.
• Discussion of advancements in targeted nuclear therapy (beta and alpha emitters).
• Overview of developments in optical phototherapy, including photoimmunotherapy.

Main Results:

• Nuclear imaging provides superior quantitativity and deep tissue penetration.
• Optical imaging offers non-ionizing properties and precise target-specific control.
• Recent advancements enable targeted therapies using both nuclear and optical methods.

Conclusions:

• Both nuclear and optical imaging technologies are crucial for in vivo molecular imaging and targeted therapies.
• Targeted nuclear therapy is advancing with alpha emitters, while photoimmunotherapy represents a significant step in optical therapy.
• The integration of these technologies holds promise for future clinical applications.